These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 10348748

  • 1. A mechanism for the synergistic antimalarial action of atovaquone and proguanil.
    Srivastava IK, Vaidya AB.
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1334-9. PubMed ID: 10348748
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite.
    Srivastava IK, Rottenberg H, Vaidya AB.
    J Biol Chem; 1997 Feb 14; 272(7):3961-6. PubMed ID: 9020100
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
    Thapar MM, Gupta S, Spindler C, Wernsdorfer WH, Björkman A.
    Trans R Soc Trop Med Hyg; 2003 Feb 14; 97(3):331-7. PubMed ID: 15228254
    [Abstract] [Full Text] [Related]

  • 6. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M, Gutteridge W, Zeman A, Dickins M, Woolley JL.
    J Travel Med; 1999 May 14; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K, Scott L.
    Drugs; 2003 May 14; 63(6):597-623. PubMed ID: 12656656
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.
    Fivelman QL, Adagu IS, Warhurst DC.
    Antimicrob Agents Chemother; 2004 Nov 14; 48(11):4097-102. PubMed ID: 15504827
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
    Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB.
    Am J Trop Med Hyg; 1999 Apr 14; 60(4):533-41. PubMed ID: 10348225
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
    Fidock DA, Nomura T, Wellems TE.
    Mol Pharmacol; 1998 Dec 14; 54(6):1140-7. PubMed ID: 9855645
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.